These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 26622842)

  • 1. Association between functional variants in BIRC5/survivin gene 3' untranslated region and mRNA expression in lymphoblastoid cell lines.
    Pu F; Shao Z; Yang S; Liu J; Lin S; Ma X; Yang H
    Oncol Lett; 2015 Oct; 10(4):2319-2322. PubMed ID: 26622842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between a functional variant at PTGS2 gene 3'UTR and its mRNA expression in lymphoblastoid cell lines.
    Wang X; Zhao Y; Wang Y; Wang Z; Guan X
    Cell Biol Int; 2013 May; 37(5):516-9. PubMed ID: 23444045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between a functional variant in
    Chen F; Zhang H; Pu F
    Springerplus; 2016; 5(1):1688. PubMed ID: 27733989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional variants at the miRNA binding sites of the E2F1 gene and its mRNA expression.
    Zhao Y; Tang L; Nie W; Wang Z; Guan X
    Oncol Lett; 2013 Jan; 5(1):398-402. PubMed ID: 23255957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms in Survivin (
    Sušac I; Ozretić P; Gregorić M; Levačić Cvok M; Sabol M; Levanat S; Trnski D; Eljuga D; Seiwerth S; Aralica G; Stanec M; Musani V
    J Oncol; 2019; 2019():3483192. PubMed ID: 31467536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-138-5p contributes to cell proliferation and invasion by targeting Survivin in bladder cancer cells.
    Yang R; Liu M; Liang H; Guo S; Guo X; Yuan M; Lian H; Yan X; Zhang S; Chen X; Fang F; Guo H; Zhang C
    Mol Cancer; 2016 Dec; 15(1):82. PubMed ID: 27978829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variation in a miR-335 binding site in BIRC5 alters susceptibility to lung cancer in Chinese Han populations.
    Zu Y; Ban J; Xia Z; Wang J; Cai Y; Ping W; Sun W
    Biochem Biophys Res Commun; 2013 Jan; 430(2):529-34. PubMed ID: 23232114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ectopic expression of BIRC5-targeting miR-101-3p overcomes bone marrow stroma-mediated drug resistance in multiple myeloma cells.
    Abdi J; Rastgoo N; Chen Y; Chen GA; Chang H
    BMC Cancer; 2019 Oct; 19(1):975. PubMed ID: 31638931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variant rs1058240 at the microRNA-binding site in the GATA3 gene may regulate its mRNA expression.
    Yang F; Chen F; Gu J; Zhang W; Luo J; Guan X
    Biomed Rep; 2014 May; 2(3):404-407. PubMed ID: 24748983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional variants of
    Pu F; Chen F; Zhang Z; Feng J; Xia P
    Future Sci OA; 2018 Jun; 4(5):FSO298. PubMed ID: 29796301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphism of Baculoviral Inhibitor of Apoptosis Repeat-Containing 5 (BIRC5) Can Be Associated with Clinical Outcome of Non-Small Cell Lung Cancer.
    Szczyrek M; Mlak R; Szudy-Szczyrek A; Wojas-Krawczyk K; Kędziora K; Milanowski J
    Cells; 2022 Mar; 11(6):. PubMed ID: 35326407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is the impact of BIRC5 gene polymorphisms on urinary cancer susceptibility? Evidence from 9348 subjects.
    Xu M; Hu X; Zhang M; Ge Y
    Gene; 2020 Apr; 733():144268. PubMed ID: 31809840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BIRC5: A novel therapeutic target for lung cancer stem cells and glioma stem cells.
    Kahm YJ; Kim RK
    Biochem Biophys Res Commun; 2023 Nov; 682():141-147. PubMed ID: 37806253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unraveling novel survivin mRNA transcripts in cancer cells using an in-house developed targeted high-throughput sequencing approach.
    Adamopoulos PG; Tsiakanikas P; Adam EE; Scorilas A
    Genomics; 2021 Jan; 113(1 Pt 2):573-581. PubMed ID: 32980523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel GPR30 rs10235056 A>G polymorphism associated with post-transcriptional regulation in lymphoblastoid cell lines.
    Zhang W; Yang F; Luo J; Chen F; Gu J; Guan X
    Biomarkers; 2014 Aug; 19(5):417-23. PubMed ID: 24893701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G-A variant in miR-200c binding site of EFNA1 alters susceptibility to gastric cancer.
    Li Y; Nie Y; Cao J; Tu S; Lin Y; Du Y; Li Y
    Mol Carcinog; 2014 Mar; 53(3):219-29. PubMed ID: 23065816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BIRC5 Gene Disruption via CRISPR/Cas9n Platform Suppress Acute Myelocytic Leukemia Progression.
    Narimani M; Sharifi M; Hakhamaneshi MS; Roshani D; Kazemi M; Hejazi SH; Jalili A
    Iran Biomed J; 2019 Nov; 23(6):369-78. PubMed ID: 31104397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockout Of
    Narimani M; Sharifi M; Jalili A
    Blood Lymphat Cancer; 2019; 9():53-61. PubMed ID: 31819702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do the survivin (BIRC5) splice variants modulate or add to the prognostic value of total survivin in breast cancer?
    Span PN; Tjan-Heijnen VC; Heuvel JJ; de Kok JB; Foekens JA; Sweep FC
    Clin Chem; 2006 Sep; 52(9):1693-700. PubMed ID: 16873289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-15a, microRNA-15b and microRNA-16 inhibit the human dopamine D1 receptor expression in four cell lines by targeting 3'UTR -12 bp to + 154 bp.
    Wu X; Xu FL; Xia X; Wang BJ; Yao J
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):276-287. PubMed ID: 31858826
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.